Gali Health

AI-Powered Platform For Personalized Medicine

Company Information

Website:

https://galihealth.com/

Sector:

Biotechnology

Location:

San Francisco, CA

Gali Health is an Artificial Intelligence-powered personal health assistant. It’s designed to help the 60% of U.S. adults suffering from chronic health conditions proactively manage their disease.

This patented platform uses individual health information and collective intelligence to create a personalized health feed for each user. By accessing the feed, patients can monitor their health history, manage their treatment plans, and receive crowdsourced information about their specific condition.

This company is led by Founder Ilya Kupershmidt, a veteran in the biotech and genomic industries. Two of his previous companies in these sectors were acquired.

In 2018, Gali Health developed a prototype of its platform, and launched a beta version in early 2019. In the meantime, it’s raised more than $2 million from professional investors including Felicis Ventures and Bold Capital.

Now it’s seeking capital to fully launch its platform. Its initial target is the $30 billion U.S. market for treatment of Inflammatory Bowel Disease.

This disease, known as IBD, for short, includes patients who suffer from Chron’s disease, ulcerative colitis, and indeterminate colitis. More than 3 million Americans suffer from IBD.

When it comes to IBD and other chronic conditions, most of the responsibility of managing the disease falls on the patient. As a result, patients turn to the Internet and social media to gather information. In addition, they use mobile technology like smart wearables to monitor their conditions.

The problem is that these resources typically provide generic information and treatment options. Gali Health, in contrast, offers personalized management.

Here’s how it works:

The platform’s main feature is a health feed called Gali Assistant. This feed is similar in concept to a user’s Facebook or LinkedIn profile.

Essentially, this feed provides information, learning programs, and illness management support through crowdsourcing. More specifically, it crowdsources health insights from patients (through content on blogs, websites, and social media platforms), and the medical community (medical journals, articles, and online resources). All that content is then personalized and presented to the user on their feed.

In addition to this information, the feed shows a user’s personal health history, as well as care instructions and reminders for medication and treatment.

Gali Assistant also features a “chat” option, where patients can communicate with the platform’s AI-bot. Patients can ask questions about their health, or inform the platform of any changes in their symptoms or treatment plan.

The second feature of Gali Health’s platform is a program currently under development called Gali Healthome. This will feature therapeutic and diagnostic programs created by gathering and analyzing information like genomes and microbiomes. This program will help patients and the medical community better understand the root causes and characteristics of chronic conditions.

To help develop its platform, the company is collaborating with researchers at Stanford Hospital and the University of California, San Francisco.

Gali Health’s beta platform is offered free to consumers. This is in an effort to increase user traction and establish a reliable brand.

In the future, revenue will come from partnerships with diagnostic companies, and Gali Health will introduce a customizable paid version of its platform for healthcare providers.

In addition, the company aims to carry out clinical studies to demonstrate its platform’s impact on patients’ quality of life, and will seek to include it into standard health plans.

The company aims to begin generating revenue in 2020, at which point it will be fully HIPPA compliant.

Team Background

Ilya Kupershmidt - Founder & CEO

Ilya has extensive entrepreneurial experience in the biotech industry, having sold two previous companies.

He co-founded NextBio, a biotech company focused on applying large-scale patient and genomic data to clinical discoveries. In 2013, the company was acquired by Illumina, a genomic sequencing company.

Prior to that, he was in charge of industry partnerships at a genomic software startup that helped scientists understand data stemming from the Human Genome Project. This startup was acquired by Agilent Technologies (NYSE: A), a laboratory instrument manufacturing company.

Ilya earned a Bachelor’s degree at the University of California, San Diego and completed graduate work at the Science for Life Labs/Karolinska Institute in Stockholm, Sweden.

Dr. David Goodman - Chief Medical Officer

In addition to his duties with Gali Health, David owns Sunday Medical Clinic. This practice provides urgent care for adults and children.

He co-founded FeetFirst, a digital health startup focused on treating diabetic foot ulcers. In addition, he was Director of the Audit department at NeuroMetrix, a healthcare company developing wearable medical technology for managing chronic diseases.

For three years, David was Chief Medical Officer for FirstVitals Health and Wellness, a diabetes monitoring program that received a $4 million CMS Innovation Grant.

He earned a Bachelor’s and Master’s degree in Bioengineering from the University of Pennsylvania, and an M.D. from Harvard Medical School.

Anatoly Volovik - Head of Product Management

Prior to joining the team at Gali Health, Anatoly was an independent consultant for 13 years.

He was a product manager for Gett, a ride-sharing startup. And for five years, he was a product designer at SpeedDate.com, an online dating service.

He earned a Bachelor’s degree in Product Design from the University of Illinois.

Anna Arutiunova - Head of Communications

Anna has a background in digital publishing and editing.

She was Director of Editorial Content for Aurora Prize, an initiative that introduced an annual international humanitarian award recognizing individuals and organizations for humanitarian work.

Prior to that, she was Digital Communications Manager for Confidence Pharmaceutical Research, and was a user support coordinator for Google News.

Anna earned a Bachelor’s degree in Mass Communications from University of California, Berkeley, and a Master’s in Publishing from NYU.

Co-Investors

Bold Capital

A VC firm investing in early-stage and growth technology companies.

Felicis Ventures

A VC firm investing in companies that are reinventing existing markets. Portfolio includes Shopify, Dollar Shave Club, and Fitbit.